Our body contains two types of cannabinoid receptors—CB1 and CB2. CB1 receptors are found in the nervous system and brain, while CB2 receptors are located in the immune system and other areas of the body. Topicals work by interacting with the body's endocannabinoid system (ECS). The ECS is a network of receptors that are found throughout the body, including the skin. Cannabinoids, the active ingredients in cannabis, can bind to these receptors and produce a variety of effects.
The ECS is involved in a number of important bodily functions, including pain perception, inflammation, and immune response. Cannabinoids can modulate the activity of the ECS, which can lead to a number of therapeutic benefits. When a cannabis topical is applied to the skin, the cannabinoids in the topical bind to the ECS receptors in the skin. However, the cannabinoids in the topical are not absorbed into the bloodstream in high enough concentrations to produce a psychoactive effect.
Some of the potential risks of using cannabis topicals:
Skin irritation
Allergic reaction
Drug interaction
The added essential oils aid in the anti-bacterial and anti-inflammatory properties of the product.